Waldschmidt, D. T., Im, N. G., Damanakis, A., Schmidt, T., Schwabedissen, A. M. Z., Quaas, A., Kehmann, L., Deuß, B., Held, S., Roderburg, C., Chikhladze, S., Mees, S. T., Werner, J., Ronellenfitsch, U., Wiltberger, G., Klotz, R., Neumann-Haefelin, C., Bruns, C. J., Gebauer, F. (2025). First safety analysis of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluoruracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4172